Zobrazeno 1 - 10
of 34 127
pro vyhledávání: '"large b-cell lymphoma"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract This study aimed to develop a PANoptosis-related gene prognostic index (PANGPI) to explore its potential value in predicting the prognosis and immunotherapy response of diffuse large B-cell lymphoma (DLBCL). Differentially expressed genes of
Externí odkaz:
https://doaj.org/article/f3caf5b2c684400d96ae70529c4164db
Autor:
Yanhong Luo, Yongao Li, Zhenhuan Yang, Yanbo Zhang, Hongmei Yu, Zhiqiang Zhao, Kai Yu, Yujiao Guo, Xueman Wang, Na Yang, Yan Zhang, Tingting Zheng, Jie Zhou
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background and objective Positron emission tomography/computed tomography (PET/CT) is recommended as the standard imaging modality for diffuse large B-cell lymphoma (DLBCL) staging. However, many studies have neglected the role of patients'
Externí odkaz:
https://doaj.org/article/a8b6db44b61c4e0c8bd5a92c3a7de2b1
Autor:
Juliette M. Kersten, MD, Anouschka N. Lenderink, BSc, Koen D. Quint, MD, PhD, Rosanne Ottevanger, MD
Publikováno v:
JAAD Case Reports, Vol 54, Iss , Pp 85-88 (2024)
Externí odkaz:
https://doaj.org/article/dfa2b08c10dc4182a997a6fb133fea38
Autor:
Greta Foiani, Luca Licenziato, Laura Marconato, Antonella Fanelli, Erica Melchiotti, Claudia Zanardello, Luca Aresu, Marta Vascellari
Publikováno v:
Veterinary Quarterly, Vol 44, Iss 1, Pp 1-9 (2024)
TP53 mutations are associated with short survival and poor treatment response in canine diffuse large B-cell lymphoma (cDLBCL). The expression of TP53 by RNAscope® in situ hybridization and p53 by immunohistochemistry (IHC) was investigated in 37 fo
Externí odkaz:
https://doaj.org/article/cf30fb8de5df4bb5baadbef7602420c8
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract The clinical phenomenon whereby diffuse large B-cell lymphoma (DLBCL) occurs in patients with a history of autoimmune disease (AD) has been noted, but it remains controversial. This study aimed to evaluate the causal associations between nin
Externí odkaz:
https://doaj.org/article/c6bb4b51b5164db8b842c64272c47ef5
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Patients diagnosed with diffuse large B-cell lymphoma (DLBCL) are at increased risk of developing atrial fibrillation (AF). Abnormal P-wave parameters (PWPs) have been identified as independent predictors of AF, however, their prognostic sig
Externí odkaz:
https://doaj.org/article/77bc5a7391bd4cc0978ec1a5f99aa65b
Autor:
Saskia Räuber, Andreas Schulte-Mecklenbeck, Alice Willison, Ramona Hagler, Marius Jonas, Duygu Pul, Lars Masanneck, Christina B. Schroeter, Kristin S. Golombeck, Stefanie Lichtenberg, Christine Strippel, Marco Gallus, Andre Dik, Ruth Kerkhoff, Sumanta Barman, Katharina J. Weber, Stjepana Kovac, Melanie Korsen, Marc Pawlitzki, Norbert Goebels, Tobias Ruck, Catharina C. Gross, Werner Paulus, Guido Reifenberger, Michael Hanke, Oliver Grauer, Marion Rapp, Michael Sabel, Heinz Wiendl, Sven G. Meuth, Nico Melzer
Publikováno v:
Journal of Neuroinflammation, Vol 21, Iss 1, Pp 1-21 (2024)
Abstract Background Immune dysregulation is a hallmark of autoimmune diseases of the central nervous system (CNS), characterized by an excessive immune response, and primary CNS tumors (pCNS-tumors) showing a highly immunosuppressive parenchymal micr
Externí odkaz:
https://doaj.org/article/848c9d49598a4962b05d92211b97ff55
Autor:
Nelly O. Elshafie, Michael Gribskov, Nathanael I. Lichti, Ekramy E. Sayedahmed, Michael O. Childress, Andrea Pires dos Santos
Publikováno v:
FEBS Open Bio, Vol 14, Iss 11, Pp 1899-1913 (2024)
Diffuse large B‐cell lymphoma (DLBCL) is the most prevalent subtype of non‐Hodgkin lymphoma (NHL) in domestic dogs, with many similarities to its human counterpart. The progression of the disease is rapid, and treatment must be initiated early to
Externí odkaz:
https://doaj.org/article/9a51b6ad30a04c1087d67b5b84f7f347
Autor:
Kristyna Kupcova, Jana Senavova, Filip Jura, Vaclav Herman, Anezka Rajmonova, Mariana Pacheco-Blanco, Tereza Chrbolkova, Iva Hamova, R. Eric Davis, Ondrej Havranek
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-6 (2024)
Abstract The phosphatidylinositol 3‑kinase/protein kinase B (PI3K/AKT) signaling pathway is critically active in many cell types, both normal and neoplastic. Many small-molecule inhibitors targeting different levels of the PI3K/AKT pathway have bee
Externí odkaz:
https://doaj.org/article/a0c2c0e551524346977216024eee5ee7
Autor:
Gloria Iacoboni, Víctor Navarro, Pierre Sesques, Kai Rejeski, Mariana Bastos-Oreiro, Fabio Serpenti, Ana Africa Martin Lopez, Josu Iraola-Truchuelo, Javier Delgado, Ariadna Perez, Manuel Guerreiro, Ana Carolina Caballero, Nuria Martinez-Cibrian, Hugo Luzardo Henriquez, Jose Maria Sanchez Pina, Juan-Manuel Sancho, Hervé Ghesquieres, Alberto Mussetti, Lucia Lopez Corral, Rafael Hernani, Juan Luis Reguera, Anna Sureda, Francesc Bosch, Alejandro Martin Garcia-Sancho, Mi Kwon, Marion Subklewe, Andrea Kuhnl, Emmanuel Bachy, Pere Barba, Guillermo Villacampa, Pau Abrisqueta
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-10 (2024)
Abstract Chimeric antigen receptor (CAR) T-cell therapy fails to achieve durable responses in over 60% of relapsed/refractory (R/R) large B-cell lymphoma (LBCL) patients in the third or later line setting. After CAR-T failure, survival outcomes are h
Externí odkaz:
https://doaj.org/article/7a33c510abd6496482324ad69e68ca9f